Through miRNA sponge technology, we demonstrated that inhibition of endogenous miR-30 in cardiomyocytes not only directly leads to pathological cardiac hypertrophy but also enhances the phosphatase activity of calcineurin and promotes nuclear translocation of NFATc3 (Figure 4 and Figure 5). The gene discussed is NFATC3; the disease is cardiac hypertrophy.